FID 072021
Latest Information Update: 10 Oct 2003
At a glance
- Originator Nonindustrial source
- Developer Fidia Farmaceutici; Nonindustrial source
- Class Analgesics; Small molecules
- Mechanism of Action Acetylcholine inhibitors; Acetylcholine stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 10 Oct 2003 Discontinued - Preclinical for Pain in Italy (unspecified route)
- 30 May 2001 Profile reviewed but no significant changes made
- 31 Aug 1998 No-Development-Reported for Pain in Italy (Unknown route)